In the evolving landscape of diabetes management, novel therapies like semaglutide and retatrutide are gaining traction. These drugs, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist family, offer https://barrygjce697020.blog-ezine.com/39428862/semaglutide-vs-retatrutide-a-novel-comparison-in-diabetes-management